Insider Transactions in Q2 2025 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 29
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+26.03%
|
$100,000
$2.43 P/Share
|
|
Apr 28
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
41,667
-31.15%
|
$1,250,010
$30.19 P/Share
|
|
Apr 28
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,667
+23.75%
|
$83,334
$2.43 P/Share
|
|
Apr 28
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,236
-1.99%
|
$97,080
$30.19 P/Share
|
|
Apr 22
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
2,936
-36.67%
|
$76,336
$26.49 P/Share
|
|
Apr 21
2025
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
33,333
-2.0%
|
$833,325
$25.98 P/Share
|
|
Apr 21
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+1.96%
|
$66,666
$2.09 P/Share
|
|
Apr 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-12.5%
|
$1,330,952
$28.23 P/Share
|
|
Apr 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
36,460
-14.57%
|
$1,020,880
$28.17 P/Share
|
|
Apr 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,668
+12.33%
|
$67,336
$2.43 P/Share
|
|
Apr 15
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-8.87%
|
$324,268
$28.5 P/Share
|
|
Apr 15
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+2.41%
|
$51,496
$8.27 P/Share
|
|
Apr 14
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,236
-1.95%
|
$90,608
$28.72 P/Share
|
|
Apr 09
2025
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
33,337
-1.01%
|
$900,099
$27.64 P/Share
|
|
Apr 09
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,337
+3.82%
|
$33,337
$1.75 P/Share
|
|
Apr 04
2025
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,380
+4.78%
|
$201,900
$5.01 P/Share
|
|
Apr 03
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
2,203
-21.58%
|
$61,684
$28.78 P/Share
|
|
Apr 02
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-8.54%
|
$335,849
$29.26 P/Share
|
|
Apr 02
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+4.53%
|
$32,185
$5.01 P/Share
|